Impairment charge sees Althea losses sink to $32m despite revenue growth by Steve Jones August 30, 2024September 2, 2024 A non-cash impairment of almost A$18 million saw Althea’s losses more than double to $32m in […]
Althea shares tumble after announcing $2m capital raise for product expansion by Steve Jones July 16, 2024July 17, 2024
Pathway to profitability ‘hugely tough’, but Althea boss keeps the faith by Steve Jones May 28, 2024May 29, 2024
Althea makes further savings as cost-cutting program continues by Steve Jones April 30, 2024April 30, 2024
Althea to cut further costs amid cash flow concerns and ongoing losses by Steve Jones March 1, 2024March 4, 2024
Company news: Bioxyne/BLS; Wellnex Life; Elixinol Wellness; Althea; Health House; Rua Bioscience by Steve Jones and Martin Lane February 7, 2024February 7, 2024
Althea losses rise but shareholders told to expect ‘significant upside’ by Steve Jones February 28, 2023April 30, 2024
Survivors of dotcom boom and bust keep us focused, says Althea boss after share price slump by Steve Jones November 4, 2022April 29, 2024
Althea heralds ‘very pleasing’ result as revenues spike and losses narrow by Steve Jones August 31, 2022April 29, 2024
Althea shares spike as revenue doubles and operating costs hit ‘all-time low’ by Steve Jones July 12, 2022April 29, 2024
